Bionomics Competitors and Similar CompaniesClear all
Bionomics's competitors and similar companies include ViroStatics, Helix BioPharma, Biocon and Shanghai Junshi Biosciences.
 Bionomics Bionomics is a clinical-stage biopharmaceutical company developing ion channels targeting drug candidates designed for patients suffering from central nervous system (CNS) disorders. |  Helix BioPharma Helix BioPharma is a biopharmaceutical company developing therapies in the field of immuno-oncology, based on its technological platform DOS47. |  Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases. | |||
Founding Date | Founding Date 1996 | Founding Date 2005 | Founding Date 1995 | Founding Date 1978 | Founding Date 2012 |
Type | Type Subsidiary | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Eastwood, AU HQ | Locations Sassari, IT HQ Tramariglio, IT | Locations Richmond Hill, CA HQ | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | Locations Shanghai, CN HQ |
Employees | Employees 7 | Employees 8 | Employees 7 | Employees 16,5612% increase | Employees 2,578 |
Financial | |||||
Revenue (est.) | Revenue (est.) $264k (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ₹167.8b (FY, 2026) | Revenue (est.) ¥2.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ₹56.9b (FY, 2026) | Cost of goods ¥466.5m (FY, 2025) |
Gross profit | Gross profit $6.1m (FY, 2022) | Gross profit N/A | Gross profit $305k (FY, 2025) | Gross profit ₹115.8b (FY, 2026) | Gross profit ¥2b (FY, 2025) |
Net income | Net income ($21.8m) (FY, 2022) | Net income N/A | Net income ($5.2m) (FY, 2025) | Net income ₹3.7b (FY, 2026) | Net income (¥1b) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 10.4m | Total funding raised $ 53k | Total funding raised $ 11.1m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Helix BioPharma
HQ
Richmond Hill, CA
Employees
7
Helix BioPharma is a biopharmaceutical company developing therapies in the field of immuno-oncology, based on its technological platform DOS47.
View company
Biocon
HQ
Bengaluru, IN
Employees
16,561↑ 2% increase
Biocon is a company that develops and manufactures biopharmaceutical products.
View companyShanghai Junshi Biosciences
HQ
Shanghai, CN
Employees
2,578
Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
View company